Prescription of hypolipidemic agents in 2001–2004
Authors:
J. Kolář; R. Bartas 1
Authors‘ workplace:
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav aplikované farmacie
; Lékárna Aqua, Karviná
1
Published in:
Čes. slov. Farm., 2007; 56, 30-36
Category:
Original Articles
Overview
The paper analyzes the development of the prescription and consumption of hypolipidemic agents from 2000 to 2004. The principal database consisted of dispensed medical prescriptions and the consumption of hypolipidemic agents was expressed in DDD, DID, financially, and in the form of proportional representation. In the year 2004 hypolipidemic agents represented 11.8 % of the total costs for medicaments (statins, 8.9 %, and 75.6 %, respectively, fibrates, 2.9 % and 24.4 %, respectively), in DDD statins, 69.0%, fibrates, 31.0 %. The most frequently prescribed preparation was simvastatin, 57.8 % DDD and 60.3 % in financial units.
Key words:
drug consumption – hypolipidemic agents – statins – fibrates
Labels
Pharmacy Clinical pharmacologyArticle was published in
Czech and Slovak Pharmacy
2007 Issue 1
Most read in this issue
- Extrusion/spheronization: an important method for the production of the pellet dosage form
- The influence of the extrusion die on pellet characteristics
- Deep vein thromboembolism in malignant diseases
- Constituents of Lilium candidum L. and their antioxidative activity